CluePoints Newsroom

Serving up the latest news and information about CluePoints

View all of our News Articles
AwardsBlogNews
December 5, 2019

CluePoints’ Risk-Based Quality Management (RBQM) Software Wins at Scrip Awards 2019

King of Prussia, PA – December 5, 2019: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, today…
Gemma Telfer
0
AwardsBlogNews
October 22, 2019

As Demand for RBx Soars CluePoints Continues Global Expansion Alongside Further Award Wins

KING OF PRUSSIA, PA – October 22, 2019: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software for clinical trials,…
cluepointsdev 0
1
BlogNews
September 10, 2019

FDA Extends CRADA with CluePoints to Further Explore a Data-Driven Approach to Quality Oversight in Clinical Trials

KING OF PRUSSIA, PA, 10 September 2019– FDA and its stakeholders have an interest in assuring the integrity of clinical trial data and the protection…
cluepointsdev 0
0
BlogNews
August 22, 2019

ICH E6 (R2) Compliance Webinar Series Available to Watch Now!

"I KNOW ICH E6 (R2) COMPLIANCE  INSISTS ON A RISK-BASED APPROACH TO RUNNING MY TRIALS, BUT HOW AM I GOING TO IMPLEMENT THIS AND REALIZE…
cluepointsdev 0
0
BlogNews
June 18, 2019

Parexel Strengthens Risk-Based Monitoring Offering with CluePoints’ New Advanced Statistical Capabilities

Strategic collaboration leverages CluePoints’ Central Statistical Monitoring (CSM) technology to enhance data quality and reduce operational costs. WAYNE, PA, June 18, 2019– Parexel, a leading…
cluepointsdev 0
0
BlogNews
April 9, 2019

CluePoints Experiences Continued Rapid Growth as Demand for RBx Rises

WAYNE, PA – April 09, 2019: CluePoints, a leading provider of Risk-Based Study Execution(RBx) and Data Quality Oversight solutions for clinical trials, has announced a…
cluepointsdev 0
0

Events

Find out where we’re headed next.

Visit our Events Section

Featured Whitepaper

ICH E6 (R2)
Summary
Paper

Created in conjunction with our peers at TUFTS Center for the Study of Drug Development, this paper provides insights on how companies are responding to ICH E6 (R2) and information on the key themes on adoption.

Learn More

Featured Webinar

ICH E6 (R2)
Webinar
Series

This recorded webinar covers all of the frequently asked Questions about ICH E6 (R2), Risk-Based Study Execution (RBx) and what’s required from a people, process & technology standpoint.

Learn More

We're Kind of a Big Deal.

2,500

Platform Users

350

Studies De-Risked

15,000

Issues Detected